| |
 |
| To view the full details of the Alchemia 2011 Annual Report please click the picture or PDF icon below: |
| |
 |
Complete 2011 Annual Report
1,997KB |
 |
|
| |
| To view the separate sections of the Alchemia 2011 Annual Report, please click on the PDF icons below: |
| |
Section |
Size |
PDF |
| 1. Introduction |
97KB |
|
| 2. Chairman & CEO's Report |
338KB |
|
| 3. Pipeline |
94KB |
|
| 4. Generic fondaparinux |
61KB |
|
| 5. Targeting drugs to tumours - HyACT |
96KB |
|
| 6. Drug discovery |
68KB |
|
| 7. Intellectual property portfolio |
36KB |
|
| 8. Strategic direction |
36KB |
|
| 9. Board of directors |
551KB |
|
| 10. Senior management |
385KB |
|
| 11. Directors' report |
133KB |
|
| 12. Corporate governance |
53KB |
|
| 13. Balance Sheet |
31KB |
|
| 14. Statement of comprehensive income |
29KB |
|
| 15. Statement of changes in equity |
31KB |
|
| 16. Cash flows statement |
29KB |
|
| 17. Note to the financial statements |
144KB |
|
| 18. Shareholder information |
35KB |
|
| 19. Glossary & Acronyms |
28KB |
|
| 20. Corporate directory |
465 KB |
|
|
| |
|
| |
| Archived Reports |
| |
|
| |
| |
ASX Code: ACL